Overview

Nebulized 3% Hypertonic Saline in the Treatment of Acute Bronchiolitis in the Emergency Department

Status:
Withdrawn
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
This is a prospective, randomized, controlled, double-blinded, clinical trial Subject : 3mo ~ 24mo. aged infants with bronchiolitis The effect of 3 % NaCl nebulizer or dexamethasone on admission rate of these infants in ED.
Phase:
Phase 4
Details
Lead Sponsor:
Seoul National University Hospital
Treatments:
BB 1101
Dexamethasone
Dexamethasone 21-phosphate
Dexamethasone acetate
Epinephrine
Epinephryl borate
Racepinephrine